CASE REPORT
Coexistence of diabetes mellitus type 1 with diffuse systemic sclerosis – case report and literature review
Submission date: 2017-03-14
Final revision date: 2017-04-06
Acceptance date: 2017-04-08
Online publication date: 2017-04-28
Publication date: 2017-04-28
Reumatologia 2017;55(2):104-107
KEYWORDS
TOPICS
ABSTRACT
Diabetic sclerodactyly is a frequently recognized skin finding that may occur in patients with diabetes mellitus but coexistence of diabetes and systemic sclerosis is rare. We describe a case of coexistence of type 1 diabetes mellitus and systemic sclerosis in 42-year-old man with the history of Raynaud’s phenomenon, progressive diffuse hardening of the skin and sclerodactyly, slowly worsening with time. The medical history included type 1 diabetes since childhood with microvascular complications. The patient presented a typical capillaroscopic scleroderma-like pattern, antinuclear antibodies and sclerotic lesions in gastrointestinal system. Summing up, our case represents the rare coexistence of autoimmune diseases like diabetes mellitus type 1 and systemic sclerosis.
REFERENCES (15)
1.
Kłubo-Gwieździńska J, Juniuk R. Zmiany skórne jako markery chorób gruczołów dokrewnych. Endokrynol Pol 2003; 54: 203-210.
2.
Thiboutot DM. Dermatological manifestations of endocrine disorders. J Clin Endocrinol Metabol 1995; 80: 3082-3088.
3.
Levin NA, Greer KE. Cutaneous manifestations of endocrine disorders. Dermatol Nursing 2001; 13: 185-195.
4.
Kenneth R, Feingold MD, Elias PM. Endocrine-skin interactions – cutaneous manifestations of pituitary disease, thyroid disease, calcium disorders and diabetes. J Am Acad Dermatol 1987; 17: 921-940.
5.
Al-Mutari N. Skin diseases seen in diabetes mellitus. Bull Kuwait Inst Med Spec 2006; 5: 30-39.
6.
Pavlović MD, Milenković T, Dinić M, et al. The prevalence of cutaneous manifestations in young patients with type 1 diabetes. Diabetes Care 2007; 30: 1964-1967.
7.
Gruson LM, Franks A. Scleroderma and diabetic sclerodactyly. Dermatol Online J 2005; 11: 3.
8.
Yosipovitch G, Hodak E, Vardi P, et al. The prevalence of cutaneous manifestations In IDDM patients and their association with diabetes risk factors and microvascular complications. Diabetes Care 1998; 21: 506-509.
9.
Foti R, Leonardi R, Rondinone R, et al. Scleroderma-like disorders. Autoimmun Rev 2008; 7: 331-339.
10.
Lambova SN, Muller-Ladner U. The specificity of capillaroscopic pattern in connective autoimmune diseases. A comparison with microvascular changes in diseases of social importance: arterial hypertension and diabetes mellitus. Mod Rheumatol 2009; 19: 600-605.
11.
Haustein UF. Scleroderma-like lesions in insulin-dependent diabetes mellitus. J Eur Acad Dermatol Venereol 1999; 13: 50-53.
12.
Firoz EF, Kamino H, Lehman TJ, et al. Morphea, diabetes mellitus type 1, and celiac disease: case report and reviev of the literature. Pediatr Dermatol 2010; 27: 48-52.
13.
Zeglaoui H, Landolsi H, Mankai A, et al. Type 1 diabetes mellitus, celiac disease, systemic lupus erythematosus and systemic scleroderma in a 15-year-old girl. Rheum Int 2010; 30: 793-795.
14.
Peralta-Amaro AL, Cruz-Dominguez Mdel P, Olvera-Acevedo A, et al. Prevalence of metabolic syndrome and insulin resistance in systemic sclerosis. Rev Med Inst Mex Seguro Soc 2015; 53: 476-483.
15.
Koumakis E, Dieude P, Avouac J, et al. Familial autoimmunity in systemic sclerosis- results of a French-based case control family study. J Rheumatol 2012; 39: 532-538.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Share
RELATED ARTICLE
| eISSN: | 2084-9834 |
| ISSN: | 0034-6233 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
